Solution For Breast Imaging Articles & Analysis: Older
21 news found
Women are increasingly aware of the cancer risk associated with breast density. QVCAD Invenia ABUS combination provides a solution that has the potential to be the preferred screening method for women with dense breast parenchyma. ...
Elizabeth Morris, and Dr. Amy Patel to its US Breast Medical Advisory Board. These appointments reinforce Kheiron’s focus on bringing its artificial intelligence solutions to the US market to help radiologists detect breast cancer earlier. ...
Seno Medical Instruments, Inc. (Seno Medical), a Texas-based medical imaging company developing breakthrough breast cancer diagnostic technology, announced an educational partnership supporting Worldwide Breast Cancer’s “Know Your Lemons” campaign starting with the Netherlands, which has one of the highest breast cancer incidence rates in the world. Through the partnership with ...
Seno Medical’s Imagio Breast Imaging System has been named a finalist in the 2022 Edison Awards competition in the Science and Medical category and Diagnostics sub-category. The Edison Awards program is an annual competition honoring excellence in new product and service development, marketing, human-centered design, and innovation. Past winners have included Fortune 500s, small start-ups, ...
NORCROSS, Ga., Feb. 1, 2022 /PRNewswire/ -- Koning, a growing medical device startup company based outside Atlanta, had a successful conclusion to 2021. The company recently finished their first Republic crowdfunding campaign, exceeding capital targets, and raising over $2.6M in only 5 months. Koning's FDA breast screening trial is also underway with participating clinics in Daytona Beach, FL and ...
A study presented at the Radiological Society of North America (RSNA)’s annual meeting showed Texas-based Seno Medical Instruments, Inc. (Seno)’s Imagio opto-acoustic ultrasound (OA/US) breast imaging provides significantly better specificity than ultrasound alone. The poster, “Performance of Optoacoustic Ultrasound with an Artificial Intelligence-based Decision Support Tool vs ...
DAYTONA BEACH, Fla., Nov. 1, 2021 /PRNewswire/ -- Koning begins an FDA screening trial this month for their no-compression, Isotropic, 3-dimensional breast imaging device. The company received FDA PMA approval for commercial, diagnostic use in 2017. Since then, the Koning Breast CT (KBCT) has been installed in clinics and universities in the US and globally. "This FDA screening trial is a major ...
Breast imaging specialists will now be able to benefit from one point of access to AI within the existing physician workflow, providing for early detection and diagnosis of breast cancer. ...
ByAidoc
Texas-based Seno Medical Instruments, Inc. (Seno) has launched its CONFIDENCE registry to evaluate the efficacy of imaging with opto-acoustic/ultrasound (OA/US) to diagnose breast abnormalities including cancer using its groundbreaking Imagio® Breast Imaging System. Approximately twelve sites will participate in the international registry, with a target of over 600 total patients ...
Aurora Technology and Healthcare Global Holdings enters the 2nd most populous continent through a collaboration with the Federal Republic of Nigeria to transform breast cancer care in Africa New York, Abuja, Boston: Representatives of the Nigerian government and Aurora Technology and Healthcare Global Holding Corp. (Aurora) are jointly announcing the signing of a landmark collaboration ...
The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based Seno Medical Instruments, Inc. (Seno) premarket approval (PMA) for its groundbreaking diagnostic breast cancer imaging technology that helps physicians better differentiate between benign and malignant breast lesions. The company’s Imagio® Breast Imaging System ...
With the COVID-19 pandemic pushing breast cancer screening to the back burner for many patients, scanner and software manufacturers have more reason than ever to bring products to the market that make scans faster and more comfortable, and helping radiologists manage their growing worklists. Here’s a look at what’s new in the last year from more than a dozen companies. Koios Medical, ...
Using artificial intelligence (AI) to analyze breast ultrasound lesions reduced interpretation time by 49% at a healthcare center in Missouri. The software is particularly helpful for lesions classified as BI-RADS 2, 3, and 4A, attendees of the Society for Imaging Informatics in Medicine’s (SIIM) virtual meeting learned on June 24. For almost a year, the women’s imaging department at ...
QView Medical and Traf Intercontinental announce a distribution agreement under which Traf International will sell QView Medical's QVCAD System to breast imaging clinics in Europe. QVCAD is the AI solution to assist the radiologist in detecting breast cancer in 3D Automated Breast Ultrasound ...
A recent survey of women in the Netherlands found that 79 percent of respondents diagnosed with breast cancer noticed symptoms prior to being diagnosed. Seno Medical Instruments, Inc. (Seno Medical), a Texas-based medical imaging company developing breakthrough breast cancer diagnostic technology, teamed up with the Know Your Lemons campaign to conduct the survey in the Netherlands, which has ...
An article recently published in Radiology highlights the groundbreaking use of a new imaging technology introduced by Seno Medical Instruments, Inc.® (Seno Medical) to diagnose breast cancer. The technology may offer physicians a new, non-invasive tool to not only better differentiate between benign and malignant breast cancers, but may also help differentiate between breast cancer molecular ...
Additional research appearing in the June online issue (open access) of European Radiology features the groundbreaking diagnostic breast cancer imaging technology introduced by Seno Medical Instruments™, Inc. (Seno Medical). This technology might not only help physicians better differentiate between benign and malignant breast lesions, but also discriminate between breast cancer molecular ...
Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today provided a summary of key 2018 data publications and presentations that demonstrate the clinical utility and healthcare economic benefits of its proprietary, cutting-edge technology. ...
Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic (OA/US) imaging to differentiate benign from malignant masses, reported results of a study demonstrating that morphologic and functional OA/US features provide a non-invasive approach to helping distinguish breast cancer molecular subtypes. The data were presented on ...
Since 2010, Aurora has successfully rolled out the dedicated breast MRI mobile service in the US. The US breast MRI mobile units are joint efforts between Aurora and US medical mobile makers such as OSHKOSH, Ellis & Watts and SMIT. In 2018, we successfully completed our collaboration with European mobile maker Lamboo Medical Mobile in Netherlands to produce a more compacted mobile unit (40 ...